4.7 Article

A Novel Mechanism of Ataxia Telangiectasia Mutated Mediated Regulation of Chromatin Remodeling in Hypoxic Conditions

期刊

出版社

FRONTIERS MEDIA SA
DOI: 10.3389/fcell.2021.720194

关键词

Ataxia Telangiectasia Mutated (ATM); hypoxia; Tip60; MDM2

资金

  1. Consejo Nacional de Ciencia y Tecnologia (CONACyT) Mexico [226081/381343]

向作者/读者索取更多资源

Genotoxic stress can activate the ATM kinase, with potential involvement of Suv39H1 and Tip60 in ATM activation under hypoxic conditions.
The effects of genotoxic stress can be mediated by activation of the Ataxia Telangiectasia Mutated (ATM) kinase, under both DNA damage-dependent (including ionizing radiation), and independent (including hypoxic stress) conditions. ATM activation is complex, and primarily mediated by the lysine acetyltransferase Tip60. Epigenetic changes can regulate this Tip60-dependent activation of ATM, requiring the interaction of Tip60 with tri-methylated histone 3 lysine 9 (H3K9me3). Under hypoxic stress, the role of Tip60 in DNA damage-independent ATM activation is unknown. However, epigenetic changes dependent on the methyltransferase Suv39H1, which generates H3K9me3, have been implicated. Our results demonstrate severe hypoxic stress (0.1% oxygen) caused ATM auto-phosphorylation and activation (pS1981), H3K9me3, and elevated both Suv39H1 and Tip60 protein levels in FTC133 and HCT116 cell lines. Exploring the mechanism of ATM activation under these hypoxic conditions, siRNA-mediated Suv39H1 depletion prevented H3K9me3 induction, and Tip60 inhibition (by TH1834) blocked ATM auto-phosphorylation. While MDM2 (Mouse double minute 2) can target Suv39H1 for degradation, it can be blocked by sirtuin-1 (Sirt1). Under severe hypoxia MDM2 protein levels were unchanged, and Sirt1 levels depleted. SiRNA-mediated depletion of MDM2 revealed MDM2 dependent regulation of Suv39H1 protein stability under these conditions. We describe a novel molecular circuit regulating the heterochromatic state (H3K9me3 positive) under severe hypoxic conditions, showing that severe hypoxia-induced ATM activation maintains H3K9me3 levels by downregulating MDM2 and preventing MDM2-mediated degradation of Suv39H1. This novel mechanism is a potential anti-cancer therapeutic opportunity, which if exploited could target the hypoxic tumor cells known to drive both tumor progression and treatment resistance.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Biochemistry & Molecular Biology

BAP1 Status Determines the Sensitivity of Malignant Mesothelioma Cells to Gemcitabine Treatment

Alice Guazzelli, Parisa Meysami, Emyr Bakker, Constantinos Demonacos, Antonio Giordano, Marija Krstic-Demonacos, Luciano Mutti

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)

Article Oncology

Sirtuin Family Members Selectively Regulate Autophagy in Osteosarcoma and Mesothelioma Cells in Response to Cellular Stress

Richa Garva, Chutamas Thepmalee, Umpa Yasamut, Sangkab Sudsaward, Alice Guazzelli, Ramkumar Rajendran, Nopprarat Tongmuang, Sasiprapa Khunchai, Parisa Meysami, Thawornchai Limjindaporn, Pa-thai Yenchitsomanus, Luciano Mutti, Marija Krstic-Demonacos, Constantinos Demonacos

FRONTIERS IN ONCOLOGY (2019)

Article Oncology

Prospective Assessment of Systemic MicroRNAs as Markers of Response to Neoadjuvant Chemotherapy in Breast Cancer

Andrew McGuire, Maire-Caitlin Casey, Ronan M. Waldron, Helen Heneghan, Olga Kalinina, Emma Holian, Ailbhe McDermott, Aoife J. Lowery, John Newell, Roisin M. Dwyer, Nicola Miller, Maccon Keane, James A. L. Brown, Michael J. Kerin

CANCERS (2020)

Article Oncology

Protein disulfide isomerase A1 regulates breast cancer cell immunorecognition in a manner dependent on redox state

Rashed Alhammad, Sasiprapa Khunchai, Nopprarat Tongmuang, Thawornchai Limjindaporn, Pa-Thai Yenchitsomanus, Luciano Mutti, Marija Krstic-Demonacos, Constantinos Demonacos

ONCOLOGY REPORTS (2020)

Article Biochemistry & Molecular Biology

Evaluation of the Role of p53 Tumour Suppressor Posttranslational Modifications and TTC5 Cofactor in Lung Cancer

Hasen Alhebshi, Kun Tian, Lipsita Patnaik, Rebecca Taylor, Pavel Bezecny, Callum Hall, Patricia Anthonia Johanna Muller, Nazila Safari, Delta Patricia Menendez Creamer, Constantinos Demonacos, Luciano Mutti, Mohamad Nidal Bittar, Marija Krstic-Demonacos

Summary: Mutations in the p53 tumor suppressor gene are common in over 50% of cancers. This study found significant associations between p53 modifications, including acetylated p53 at K382, phosphorylated p53 at S46, and TTC5 protein, with tumor grade and overall survival in lung cancer patients. The results suggest that analyzing p53 modifications and TTC5 expression could be useful prognostic factors or drug targets for lung cancer treatment when tested on a larger patient sample size.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)

Article Oncology

Protein disulfide isomerase A1-associated pathways in the development of stratified breast cancer therapies

Emyr Yosef Bakker, Masayuki Fujii, Marija Krstic-Demonacos, Constantinos Demonacos, Rashed Alhammad

Summary: The study reveals the differential roles of PDIA1 in ERα-positive and ERα-negative breast cancer patients, providing insights into the pathways regulating carcinogenesis and potential therapeutic targets.

INTERNATIONAL JOURNAL OF ONCOLOGY (2022)

Review Cell Biology

Recent Advances in the Role of Discoidin Domain Receptor Tyrosine Kinase 1 and Discoidin Domain Receptor Tyrosine Kinase 2 in Breast and Ovarian Cancer

Li Chen, Xiangyi Kong, Yi Fang, Shishir Paunikar, Xiangyu Wang, James A. L. Brown, Emer Bourke, Xingrui Li, Jing Wang

Summary: Discoidin domain receptor tyrosine kinases (DDRs) are a type of receptor tyrosine kinases associated with various diseases, widely expressed in different cell types and involved in signaling pathways, closely related to the development and progression of solid tumors.

FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2021)

Editorial Material Biochemistry & Molecular Biology

Editorial: Cancer Therapeutics: Targeting DNA Repair Pathways

Amila Suraweera, James A. L. Brown, Yi Chieh Lim, Martin F. Lavin

FRONTIERS IN MOLECULAR BIOSCIENCES (2022)

Editorial Material Cell Biology

Editorial: Mechanisms guarding the genome

James A. L. Brown, E. Bourke, W. W. Hancock, D. J. Richard

FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2022)

Article Multidisciplinary Sciences

Profiling leadership: Attitudes, knowledge and training in the biological sciences

James A. L. Brown

Summary: This study shows that academic staff in the biological sciences are eager to receive formal leadership skills training, but there is no clear evidence that they have received such training. The study also found that they are more interested in systemic leadership, which is lacking in the workplace. Therefore, specific leadership skills training should be incorporated into professional development programs in the field of biological sciences.

PLOS ONE (2023)

Article Oncology

Peripheral Blood Cell Ratios as Prognostic Indicators in a Neoadjuvant Chemotherapy-Treated Breast Cancer Cohort

Amirhossein Jalali, David Miresse, Matthew R. Fahey, Niamh Ni Mhaonaigh, Andrew McGuire, Emer Bourke, Michael J. Kerin, James A. L. Brown

Summary: The study demonstrates the prognostic value of systemic blood-based immunocyte ratios in neoadjuvant chemotherapy-treated breast cancer patients, with significant associations found between different immunocyte ratios and subtype-specific outcomes.

CURRENT ONCOLOGY (2022)

Article Pharmacology & Pharmacy

Patent spotlight: small-molecule lysine acetyltransferase inhibitors (KATi)

James A. L. Brown

PHARMACEUTICAL PATENT ANALYST (2020)

暂无数据